BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34698089)

  • 1. Prostate Magnetic Resonance Imaging Analyses, Clinical Parameters, and Preoperative Nomograms in the Prediction of Extraprostatic Extension.
    Majchrzak N; Cieśliński P; Głyda M; Karmelita-Katulska K
    Clin Pract; 2021 Oct; 11(4):763-774. PubMed ID: 34698089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
    Zanelli E; Giannarini G; Cereser L; Zuiani C; Como G; Pizzolitto S; Crestani A; Valotto C; Ficarra V; Girometti R
    J Magn Reson Imaging; 2019 Nov; 50(5):1604-1613. PubMed ID: 30957321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
    PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?
    Jansen BHE; Nieuwenhuijzen JA; Oprea-Lager DE; Yska MJ; Lont AP; van Moorselaar RJA; Vis AN
    Urol Oncol; 2019 Mar; 37(3):181.e1-181.e6. PubMed ID: 30558983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy.
    Soeterik TFW; van Melick HHE; Dijksman LM; Küsters-Vandevelde H; Stomps S; Schoots IG; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2022 Jun; 5(3):328-337. PubMed ID: 32972895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis.
    Zhu M; Gao J; Han F; Yin L; Zhang L; Yang Y; Zhang J
    Insights Imaging; 2023 Aug; 14(1):140. PubMed ID: 37606802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
    Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
    J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-Stop-Shop Whole-Body
    Thalgott M; Düwel C; Rauscher I; Heck MM; Haller B; Gafita A; Gschwend JE; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2018 Dec; 59(12):1850-1856. PubMed ID: 29794224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Extraprostatic Extension Grade: Accuracy and Clinical Incremental Value in the Assessment of Extraprostatic Cancer.
    Xiang JY; Huang XS; Xu JX; Huang RH; Zheng XZ; Xue LM; Liu YL
    Biomed Res Int; 2022; 2022():3203965. PubMed ID: 36082151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining prostate health index and multiparametric magnetic resonance imaging may better predict extraprostatic extension after radical prostatectomy.
    Huang YP; Lin TP; Shen SH; Cheng WM; Huang TH; Huang IS; Fan YH; Lin CC; Huang EYH; Chung HJ; Lu SH; Chang YH; Lin ATL; Huang WJ
    J Chin Med Assoc; 2023 Jan; 86(1):52-56. PubMed ID: 36346752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of prostate multiparametric MRI for prediction of prostate cancer extra-prostatic extension according to NCCN risk categories: implication for surgical planning.
    Falagario UG; Jambor I; Ratnani P; Martini A; Treacy PJ; Wajswol E; Lantz A; Papastefanou G; Weil R; Phillip D; Lewis S; Haines K; Cormio L; Carrieri G; Kyprianou N; Wiklund P; Tewari AK
    Minerva Urol Nefrol; 2020 Dec; 72(6):746-754. PubMed ID: 32182231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S
    Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of the different versions of Partin tables in predicting extraprostatic extension of prostate cancer: a systematic review and meta-analysis.
    Eissa A; Elsherbiny A; Zoeir A; Sandri M; Pirola G; Puliatti S; Del Prete C; Sighinolfi MC; Micali S; Rocco B; Bianchi G
    Minerva Urol Nefrol; 2019 Oct; 71(5):457-478. PubMed ID: 30957478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transperineal template saturation and conventional biopsy for stage prediction in prostate cancer.
    Lehner F; Crippa A; Sigg S; Eberli D; Mortezavi A
    BJU Int; 2023 Dec; 132(6):696-704. PubMed ID: 37704215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
    Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
    Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extension.
    Sayyid R; Perlis N; Ahmad A; Evans A; Toi A; Horrigan M; Finelli A; Zlotta A; Kulkarni G; Hamilton R; Morash C; Fleshner N
    BJU Int; 2017 Jul; 120(1):76-82. PubMed ID: 27930844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.
    Girometti R; Pancot M; Signor MA; Urbani M; Balestreri L; Zuiani C
    Radiol Med; 2018 Oct; 123(10):778-787. PubMed ID: 29752647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.
    Heetman JG; van der Hoeven EJRJ; Rajwa P; Zattoni F; Kesch C; Shariat S; Dal Moro F; Novara G; La Bombara G; Sattin F; von Ostau N; Pötsch N; Baltzer PAT; Wever L; Van Basten JPA; Van Melick HHE; Van den Bergh RCN; Gandaglia G; Soeterik TFW;
    Prostate Cancer Prostatic Dis; 2023 Nov; ():. PubMed ID: 37932522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.